Browsing by author "Else, Monica"
Now showing items 1-6 of 6
-
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
Wojdacz, TK; Amarasinghe, HE; Kadalayil, L; Beattie, A; Forster, J; et al. (American Society of Hematology, 2019-08-27)<jats:title>Abstract</jats:title><jats:p>Chronic lymphocytic leukemia patients with mutated immunoglobulin heavy-chain genes (IGHV-M), particularly those lacking poor-risk genomic lesions, often respond well to chemoimmunotherapy ... -
Clinical Significance of TP53, BIRC3, ATM and MAPK-ERK genes in Chronic Lymphocytic Leukaemia: Data from the Randomised UK LRF CLL4 Trial
Else, M; Morilla, R; Catovsky, D -
ISBN 978-3-030-11391-9
Else, M; Catovsky, D; Hallek, M; Eichhorst, B; Catovsky, D (Springer, 2019-03-01) -
NON-CODING NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKAEMIA; THEIR CLINICAL IMPACT IN THE CLL4 CLINICAL TRIAL
Larrayoz, M; Rose-Zerilli, MJ; Parker, H; Blakemore, SJ; Forster, J; et al. (FERRATA STORTI FOUNDATION, 2016-06-01) -
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.
Oscier, D; Else, M; Matutes, E; Morilla, R; Strefford, JC; et al. (WILEY, 2016-09-01)Historically, an increase in the percentage and number of circulating prolymphocytes in chronic lymphocytic leukaemia (CLL) has been associated with strong expression of surface immunoglobulin, trisomy 12 and a poor outcome. ...